FLEXIBZUMAB

Pharmaceutical preparations, namely, a drug delivery system comprising monoclonal antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD), the forgoing containing monoclonal antibodies; monoclonal antibodies for medical and veterinary purposes; monoclonal antibody preparations for therapeutic purposes; monoclonal antibodies for targeting drugs to calcified tissue for therapeutic purposes